Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.84%
After-hours: Aug 15, 2025, 07:57 PM EDT
13F Institute Ownership
Total Institutes of 128 in Lineage Cell Therapeutics expanded their positions with an increase of 3 investors compared to the previous quarter. An additional 2.23M shares, as total invested capital declined by $4.15M with ownership percentage dropping from 56.73% to 48.37%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.375
0.38
Call Flow 8,000
73%
Put Flow 3,000
27%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Broadwood Capital Inc | 21.92% | 49.56M | +18.95% | 22.38M | 1.81% | May 15, 2025 |
| Blackrock, Inc. | 5.07% | 11.45M | +13.46% | 5.17M | < 0.01% | May 02, 2025 |
| Vanguard Group Inc | 3.95% | 8.92M | +3.31% | 4.03M | < 0.01% | May 09, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.